Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Response to comment on: Richter et al. Serum levels of the adipokine progranulin depend on renal function. Diabetes Care 2013;36:410-414.

Richter J, Ebert T, Stolzenburg JU, Dietel A, Hopf L, Hindricks J, Kralisch S, Kratzsch J, Fasshauer M.

Diabetes Care. 2013 Jun;36(6):e84. doi: 10.2337/dc12-2705. No abstract available.

2.

Comment on: Richter et al. Serum levels of the adipokine progranulin depend on renal function. Diabetes Care 2013;36:410-414.

Triebel J.

Diabetes Care. 2013 Jun;36(6):e83. doi: 10.2337/dc12-2275. No abstract available.

3.

Serum levels of the adipokine progranulin depend on renal function.

Richter J, Focke D, Ebert T, Kovacs P, Bachmann A, Lössner U, Kralisch S, Kratzsch J, Beige J, Anders M, Bast I, Blüher M, Stumvoll M, Fasshauer M.

Diabetes Care. 2013 Feb;36(2):410-4. doi: 10.2337/dc12-0220. Epub 2012 Oct 1.

4.

Low serum progranulin predicts the presence of mutations: a prospective study.

Schofield EC, Halliday GM, Kwok J, Loy C, Double KL, Hodges JR.

J Alzheimers Dis. 2010;22(3):981-4. doi: 10.3233/JAD-2010-101032.

PMID:
20858962
5.

Serum progranulin as an independent marker of liver fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease.

Yilmaz Y, Eren F, Yonal O, Polat Z, Bacha M, Kurt R, Ozturk O, Avsar E.

Dis Markers. 2011;31(4):205-10. doi: 10.3233/DMA-2011-0815.

6.

Serum concentration and kidney expression of salusin-α and salusin-β in rats with metabolic syndrome induced by fructose.

Sahin I, Aydin S.

Biotech Histochem. 2013 May;88(3-4):153-60. doi: 10.3109/10520295.2012.744848. Epub 2012 Dec 17.

PMID:
23244237
7.

Identification of influencing variables on adiponectin serum levels in diabetes mellitus type 1 and type 2.

Schäffler A, Herfarth H, Paul G, Ehling A, Müller-Ladner U, Schölmerich J, Zietz B.

Exp Clin Endocrinol Diabetes. 2004 Jul;112(7):383-9.

PMID:
15239024
8.

Further evidence for plasma progranulin as a biomarker in bipolar disorder.

Kittel-Schneider S, Weigl J, Volkert J, Geßner A, Schmidt B, Hempel S, Kiel T, Olmes DG, Bartl J, Weber H, Kopf J, Reif A.

J Affect Disord. 2014 Mar;157:87-91. doi: 10.1016/j.jad.2014.01.006. Epub 2014 Jan 25.

PMID:
24581833
9.

Adiponectin in youth: response to Bacha et al.

Stefan N, Stumvoll M, Häring HU, Fritsche A.

Diabetes Care. 2004 Jun;27(6):1519-20; author reply 1520-1. No abstract available.

PMID:
15161816
10.

Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function.

Guebre-Egziabher F, Bernhard J, Funahashi T, Hadj-Aissa A, Fouque D.

Nephrol Dial Transplant. 2005 Jan;20(1):129-34. Epub 2004 Dec 7.

PMID:
15585515
11.

Serum progranulin levels in patients with frontotemporal lobar degeneration and Alzheimer's disease: detection of GRN mutations in a Spanish cohort.

Antonell A, Gil S, Sánchez-Valle R, Balasa M, Bosch B, Prat MC, Chiollaz AC, Fernández M, Yagüe J, Molinuevo JL, Lladó A.

J Alzheimers Dis. 2012;31(3):581-91. doi: 10.3233/JAD-2012-112120.

PMID:
22647257
12.

Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration.

Ghidoni R, Benussi L, Glionna M, Franzoni M, Binetti G.

Neurology. 2008 Oct 14;71(16):1235-9. doi: 10.1212/01.wnl.0000325058.10218.fc. Epub 2008 Sep 3.

PMID:
18768919
13.

Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study.

Becker B, Kronenberg F, Kielstein JT, Haller H, Morath C, Ritz E, Fliser D; MMKD Study Group.

J Am Soc Nephrol. 2005 Apr;16(4):1091-8. Epub 2005 Mar 2.

14.

Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members.

Finch N, Baker M, Crook R, Swanson K, Kuntz K, Surtees R, Bisceglio G, Rovelet-Lecrux A, Boeve B, Petersen RC, Dickson DW, Younkin SG, Deramecourt V, Crook J, Graff-Radford NR, Rademakers R.

Brain. 2009 Mar;132(Pt 3):583-91. doi: 10.1093/brain/awn352. Epub 2009 Jan 21.

15.

Altered glucose homeostasis is associated with increased serum apelin levels in type 2 diabetes mellitus.

Cavallo MG, Sentinelli F, Barchetta I, Costantino C, Incani M, Perra L, Capoccia D, Romeo S, Cossu E, Leonetti F, Agati L, Baroni MG.

PLoS One. 2012;7(12):e51236. doi: 10.1371/journal.pone.0051236. Epub 2012 Dec 5.

16.

Serum biomarker for progranulin-associated frontotemporal lobar degeneration.

Sleegers K, Brouwers N, Van Damme P, Engelborghs S, Gijselinck I, van der Zee J, Peeters K, Mattheijssens M, Cruts M, Vandenberghe R, De Deyn PP, Robberecht W, Van Broeckhoven C.

Ann Neurol. 2009 May;65(5):603-9. doi: 10.1002/ana.21621.

PMID:
19288468
17.

Progranulin mutations are a common cause of FTLD in Northern Italy.

Benussi L, Ghidoni R, Binetti G.

Alzheimer Dis Assoc Disord. 2010 Jul-Sep;24(3):308-9. doi: 10.1097/WAD.0b013e3181d1bb13. No abstract available.

PMID:
20798611
18.

Progranulin gene variability and plasma levels in bipolar disorder and schizophrenia.

Galimberti D, Dell'Osso B, Fenoglio C, Villa C, Cortini F, Serpente M, Kittel-Schneider S, Weigl J, Neuner M, Volkert J, Leonhard C, Olmes DG, Kopf J, Cantoni C, Ridolfi E, Palazzo C, Ghezzi L, Bresolin N, Altamura AC, Scarpini E, Reif A.

PLoS One. 2012;7(4):e32164. doi: 10.1371/journal.pone.0032164. Epub 2012 Apr 10.

19.

Serum interleukin-18 binding protein increases with behavior different from IL-18 in patients with diabetic nephropathy.

Fujita T, Shimizu C, Fuke Y, Satomura A, Abe M, Kaizu K, Matsumoto K, Soma M.

Diabetes Res Clin Pract. 2011 Jun;92(3):e66-9. doi: 10.1016/j.diabres.2011.02.028. Epub 2011 Mar 26.

PMID:
21440322
20.

Role of progranulin as a biomarker for Alzheimer's disease.

Sleegers K, Brouwers N, Van Broeckhoven C.

Biomark Med. 2010 Feb;4(1):37-50. Review.

PMID:
20387302

Supplemental Content

Support Center